by Eric Larkin | Nov 4, 2021 | All Posts, Press Releases
San Diego, Calif., November 4, 2021 – Plexium Inc., (Plexium), a leading next-generation targeted protein degradation (TPD) company, today announced the appointment of experienced biopharmaceutical leader Percival Barretto-Ko as President and Chief Executive Officer...
by Eric Larkin | Oct 7, 2021 | All Posts, Press Releases
SAN DIEGO, Oct. 5, 2021 – Plexium Inc., (Plexium), a biotech company focused on discovering and developing protein degrading therapeutics directed towards historically challenging drug targets, today announced that company management will present and host one-on-one...
by Eric Larkin | Jan 21, 2021 | All Posts, Press Releases
Company also announces appointment of biotech veteran Mike Grey as Chairman of the Board SAN DIEGO, October 19, 2020 – Plexium Inc., a biotech company focused on discovering and developing protein degrading therapeutics directed towards historically challenging drug...
by Eric Larkin | Oct 17, 2019 | All Posts, Press Releases
Funds will help advance Plexium’s DELPhe platform to discover novel E3 ligase-modulating therapeutics to treat cancer and neurodegenerative diseases SAN DIEGO, October 17, 2019 – Plexium today announced the launch of the company with the closing of a $28 million...
by Eric Larkin | Oct 9, 2019 | All Posts, Events
Plexium CEO Swamy Vijayan to present at the North American Protein Degradation Congress in San Diego, CA on February 4-5, 2020.
by Eric Larkin | Oct 8, 2019 | All Posts, Events
Plexium CEO Swamy Vijayan to present at the Targeted Protein Degradation Summit in Boston on October 23, 2019.
